IL143691A0 - Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings - Google Patents

Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings

Info

Publication number
IL143691A0
IL143691A0 IL14369199A IL14369199A IL143691A0 IL 143691 A0 IL143691 A0 IL 143691A0 IL 14369199 A IL14369199 A IL 14369199A IL 14369199 A IL14369199 A IL 14369199A IL 143691 A0 IL143691 A0 IL 143691A0
Authority
IL
Israel
Prior art keywords
conversion
controlled release
gelatin capsules
liquid filled
release systems
Prior art date
Application number
IL14369199A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of IL143691A0 publication Critical patent/IL143691A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14369199A 1998-12-17 1999-12-10 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings IL143691A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11263498P 1998-12-17 1998-12-17
PCT/US1999/030341 WO2000035419A2 (fr) 1998-12-17 1999-12-10 Transformation de capsules de gelatine remplies de fluide en systemes a liberation regulee a l'aide de revetements multiples

Publications (1)

Publication Number Publication Date
IL143691A0 true IL143691A0 (en) 2002-04-21

Family

ID=22345016

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14369199A IL143691A0 (en) 1998-12-17 1999-12-10 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
IL143691A IL143691A (en) 1998-12-17 2001-06-11 Turning liquid-filled gelatin capsules into controlled release systems using multiple coatings

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143691A IL143691A (en) 1998-12-17 2001-06-11 Turning liquid-filled gelatin capsules into controlled release systems using multiple coatings

Country Status (21)

Country Link
US (2) US6419952B2 (fr)
EP (1) EP1140012B1 (fr)
JP (1) JP2002532406A (fr)
KR (1) KR100634069B1 (fr)
CN (1) CN1161101C (fr)
AT (1) ATE260642T1 (fr)
AU (1) AU765909C (fr)
CA (1) CA2354472C (fr)
CO (1) CO5271648A1 (fr)
DE (1) DE69915346T2 (fr)
DK (1) DK1140012T3 (fr)
ES (1) ES2213404T3 (fr)
HK (1) HK1040632A1 (fr)
HU (1) HUP0104721A3 (fr)
IL (2) IL143691A0 (fr)
MX (1) MXPA01006108A (fr)
NO (1) NO20012959L (fr)
NZ (1) NZ512410A (fr)
PT (1) PT1140012E (fr)
WO (1) WO2000035419A2 (fr)
ZA (1) ZA200104928B (fr)

Families Citing this family (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142896A0 (en) * 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
CN1161101C (zh) * 1998-12-17 2004-08-11 阿尔扎有限公司 用多层包衣将填充液体的明胶胶囊转变成控制释放的系统
JP2003516345A (ja) * 1999-12-09 2003-05-13 アルザ・コーポレーション 抗ウイルス剤
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
US6720002B2 (en) * 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
WO2003053400A1 (fr) * 2001-12-19 2003-07-03 Alza Corporation Composition et dosage pour l'administration controlee d'agents therapeutiques
KR20040066177A (ko) * 2001-12-19 2004-07-23 알자 코포레이션 친수성 거대분자의 경구 생체이용률을 증가시키기 위한제형 및 투여 형태
BR0312429A (pt) * 2002-06-26 2005-04-19 Alza Corp Pistão de deformidade mìnima e de volume eficiente para sistemas de distribuição de drogas por osmose
JP2005533084A (ja) * 2002-06-28 2005-11-04 アルザ・コーポレーシヨン 液体の有効成分の製剤を含んでなりかつ膨張可能な浸透圧組成物によりその放出を制御する経口の投薬形態
AR040301A1 (es) * 2002-06-28 2005-03-23 Alza Corp Composicion osmotica expansible y suspension para revestimiento mejoradas
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
PT1539115E (pt) * 2002-07-29 2008-01-14 Alza Corp Métodos e formas de dosagem para libertação controlada de paliperidona
BR0315454A (pt) * 2002-10-21 2005-08-23 Givaudan Sa Composições pesticidas
AU2003291667A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
EP1556017A1 (fr) * 2002-10-31 2005-07-27 ALZA Corporation Forme dosifiee permettant d'obtenir une liberation a vitesse croissante d'une formulation liquide
US7988993B2 (en) * 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
CA2530113C (fr) 2003-06-26 2013-08-13 Control Delivery Systems, Inc. Systemes d'administration de medicaments a liberation prolongee bioerodables
DE602004016995D1 (de) 2003-06-26 2008-11-20 Control Delivery Sys Inc In-situ gelierendes arzneimittelabgabesystem
SI1635787T1 (sl) * 2003-06-26 2012-04-30 Psivida Inc Bioeredibilni sistemi za oddajanje zdravil z zadrževanim sproščanjem
US20050003070A1 (en) * 2003-07-03 2005-01-06 Foster David V. Shelf stable vitamin C in oatmeal products
MXPA06000363A (es) * 2003-07-11 2006-03-28 Hoffmann La Roche Forma de dosificacion oral de mesilato de saquinavir.
ES2592504T3 (es) * 2003-07-17 2016-11-30 Banner Life Sciences, LLC Preparaciones de liberación controlada
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
KR20060054396A (ko) * 2003-07-31 2006-05-22 알자 코포레이션 액체 활성성분 제제의 방출 제어를 위한 침투-저항 삼투성엔진 및 제형
AP1899A (en) * 2003-08-08 2008-10-10 Biovail Lab Int Srl Modified-release tablet of bupropion hydrochloride
US20050260268A1 (en) * 2003-09-26 2005-11-24 Modi Nishit B Methods and dosage forms for controlled delivery of alprazolam
WO2005041935A1 (fr) * 2003-10-21 2005-05-12 Alpharma, Inc. Preparations pharmaceutiques contenant de la quetiapine
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
EP1593376A1 (fr) * 2004-05-04 2005-11-09 Warner-Lambert Company LLC Gélules de pullulane ameliorées
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
SG157415A1 (en) 2004-11-23 2009-12-29 Adamas Pharmaceuticals Inc Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
CA2588296A1 (fr) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition et methode pour traiter des affections neurologiques
WO2006063078A2 (fr) * 2004-12-08 2006-06-15 Elan Corporation, Plc Composition pharmaceutique de topiramate
US20090292013A1 (en) * 2004-12-14 2009-11-26 Caroline Sautter In-Situ Forming Implant for Animals
CA2596029A1 (fr) * 2005-01-27 2006-08-03 David E. Edgren Forme galenique osmotique orale comprenant une membrane a flux eleve
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006121560A2 (fr) * 2005-04-06 2006-11-16 Adamas Pharmaceuticals, Inc. Procedes et compositions pour le traitement des pathologies associees au systeme nerveux central
CA2605180A1 (fr) * 2005-04-19 2006-10-26 Alza Corporation Combinaison de tramadol et de matieres renfermant la gabapentine
WO2007037790A2 (fr) * 2005-06-08 2007-04-05 Elan Corporation, Plc Compositions famciclovir à libération modifiée
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
EP1945185B1 (fr) * 2005-10-12 2016-02-03 Proventiv Therapeutics, LLC Procédés et articles servant à traiter l'insuffisance et la déficience en 25-hydroxyvitamine d
US20070208041A1 (en) * 2005-10-13 2007-09-06 Stamler Jonathan S Compositions for the treatment and prevention of heart disease and methods of using same
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
HUE056937T2 (hu) 2006-02-03 2022-04-28 Opko Renal Llc A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
PT2679228T (pt) 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
US20080038334A1 (en) * 2006-08-08 2008-02-14 John Zazula Method for producing and a system for cooling a hot-filled softgel capsule
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
EP2106732B1 (fr) * 2007-01-30 2016-03-16 Olympus Corporation Dispositif permettant de contrôler le passage d'une lumière et procédé de production d'un dispositif permettant de contrôler le passage d'une lumière
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
WO2008134518A2 (fr) 2007-04-25 2008-11-06 Cytochroma Inc. Procédés et composés pour une thérapie à base de vitamine d
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
WO2008134523A1 (fr) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Procédé sûr et efficace de traitement et de prévention de l'hyperparathyroïdie secondaire dans les maladies rénales chroniques
KR101959952B1 (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
ES2574836T3 (es) * 2007-06-08 2016-06-22 Boehringer Ingelheim International Gmbh Formulación de liberación prolongada de nevirapina
CN101801350A (zh) 2007-08-13 2010-08-11 阿巴斯迪特宁医药有限公司 抗滥用药物、使用方法和制备方法
EP2537506A1 (fr) * 2007-10-15 2012-12-26 Capsugel Belgium NV Dispositifs de liaison pour formes posologiques à éléments multiples et permettant l'administration d'une ou plusieurs compositions pharmaceutiques, et formes posologiques en résultant
WO2009050192A1 (fr) * 2007-10-15 2009-04-23 Glaxo Group Limited Enveloppes de capsule à panneaux pour la libération de compositions pharmaceutiques
US8293159B2 (en) * 2007-10-15 2012-10-23 Capsugel Belgium Method and apparatus for manufacturing filled linkers
US20090110724A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of pain
JP5849328B2 (ja) * 2007-11-05 2016-01-27 アラ ワイ ファーマ インコーポレイテッド 経口投与極性剤の生物利用能を増強する製剤
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
AU2008343787B2 (en) 2007-12-28 2014-01-30 Impax Laboratories, Llc Controlled release formulations of levodopa and uses thereof
EP2240155B1 (fr) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Dispositifs, formulations et méthodes d administration de plusieurs agents bénéfiques
WO2009124210A1 (fr) 2008-04-02 2009-10-08 Cytochroma Inc. Procédés, compositions, utilisations, et kits utiles pour la carence en vitamine d et des troubles associés
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
EP2416782A1 (fr) * 2009-04-09 2012-02-15 Alkermes Pharma Ireland Limited Compositions de clozapine à libération contrôlée
WO2010147978A1 (fr) 2009-06-16 2010-12-23 Pfizer Inc. Formes posologiques d'apixaban
WO2011006066A1 (fr) 2009-07-10 2011-01-13 Ironwood Pharmaceuticals, Inc. Agonistes des récepteurs cb
CN101596174B (zh) * 2009-07-13 2011-04-06 北京航洋胶囊技术有限公司 一种软胶囊及其制备方法
CN107638562B (zh) 2009-09-28 2022-12-02 精达制药公司 基本稳态药物递送的快速建立和/或终止
AU2010300475A1 (en) 2009-09-30 2012-05-03 The Regents Of The University Of California Cofactors and methods for use for individuals
EP2488162A2 (fr) 2009-10-16 2012-08-22 Ranbaxy Laboratories Limited Compositions pharmaceutiques à libération prolongée de palipéridone et leurs procédés de préparation
BR112012013487A2 (pt) 2009-12-02 2017-10-03 Adamas Pharmaceuticals Inc Composições de amantadina e métodos de uso
JP5731538B2 (ja) 2009-12-23 2015-06-10 アイアンウッド ファーマシューティカルズ インコーポレイテッド Ｃｒｔｈ２モジュレーター
WO2011100324A1 (fr) 2010-02-09 2011-08-18 Ironwood Pharmaceuticals Inc. Agonistes des récepteurs cannabinoïdes
US20130178453A1 (en) 2010-02-09 2013-07-11 Ironwood Pharmaceuticals, Inc. Cannabinoid Agonists
US20130178475A1 (en) 2010-03-17 2013-07-11 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
US8486013B2 (en) * 2010-03-18 2013-07-16 Biotronik Ag Balloon catheter having coating
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
JP5894574B2 (ja) 2010-04-22 2016-03-30 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
WO2011161666A2 (fr) * 2010-06-21 2011-12-29 White Innovation Ltd. Inclusion de liquides dans des capsules
DK2588465T3 (en) 2010-06-30 2017-05-01 Ironwood Pharmaceuticals Inc SGC stimulators
US20130216552A1 (en) 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2012009134A1 (fr) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Modulateurs de crth2
CN107266433A (zh) 2010-11-09 2017-10-20 铁木医药有限公司 sGC刺激剂
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP3466418A1 (fr) 2011-07-15 2019-04-10 NuSirt Sciences, Inc. Compositions et procédés pour moduler les voies métaboliques
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
CA2861804C (fr) 2011-12-27 2021-10-26 Ironwood Pharmaceuticals, Inc. Pyrazoles 2-benzyle, 3-(pyrimidin-2-yle)-substitues utiles comme stimulateurs de scg
CN103211797B (zh) * 2012-01-18 2017-06-06 北京天衡医院管理有限公司 盐酸维拉帕米膜控缓释微丸胶囊
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
WO2013155422A1 (fr) 2012-04-12 2013-10-17 Ironwood Pharmaceuticals, Inc. Procédés permettant de traiter l'alopécie et l'acné
ES2727815T3 (es) 2012-04-14 2019-10-18 Intra Cellular Therapies Inc Tratamiento del TEPT y de trastornos del control de impulsos
BR112014026614A2 (pt) * 2012-04-30 2017-06-27 Dow Agrosciences Llc veículos de administração de composições pesticidas
WO2014017756A1 (fr) * 2012-07-23 2014-01-30 삼성정밀화학(주) Composition aqueuse pour la préparation d'une capsule dure, son procédé de préparation, capsule dure et procédé de recyclage des déchets de capsule dure
WO2014047111A1 (fr) 2012-09-18 2014-03-27 Ironwood Pharmaceuticals, Inc. Stimulateurs de la sgc
CA2885645A1 (fr) 2012-09-19 2014-03-27 Ironwood Pharmaceuticals, Inc. Stimulateurs de sgc
BR112015010947A2 (pt) 2012-11-13 2018-06-05 Nusirt Sciences Inc composições e métodos para aumentar o metabolismo energético.
WO2014113404A1 (fr) 2013-01-15 2014-07-24 Nusirt Sciences, Inc. Traitement de maladies pulmonaires
GB201303781D0 (en) 2013-03-04 2013-04-17 Gauthier Pierre Pascal Oral timer device and method of using same
BR112015023310A2 (pt) 2013-03-15 2017-07-18 Nusirt Sciences Inc composições, métodos e kits para redução de níveis lipídicos
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US20140275038A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
EP2968320B1 (fr) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Composés organiques
CN109369635B (zh) 2013-03-15 2023-06-30 赛克里翁治疗有限公司 化合物或其药学上可接受的盐及其应用和药物组合物
CN103315973B (zh) * 2013-05-24 2014-05-07 杭州和正医药有限公司 喹硫平的渗透泵型控释制剂
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
EP2839853A1 (fr) * 2013-08-23 2015-02-25 LTS LOHMANN Therapie-Systeme AG Système thérapeutique transdermique doté d'un dispositif de génération de pression
CN105658211A (zh) 2013-10-07 2016-06-08 怡百克制药公司 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
KR102495941B1 (ko) 2013-12-03 2023-02-06 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
US20160311826A1 (en) 2013-12-11 2016-10-27 Ironwood Pharmaceuticals, Inc. Sgc stimulators
KR102161001B1 (ko) * 2013-12-31 2020-09-29 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
KR102199596B1 (ko) * 2013-12-31 2021-01-07 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
WO2015131152A1 (fr) 2014-02-27 2015-09-03 Nusirt Sciences Inc. Compositions et procédés permettant la réduction ou la prévention de stéatose hépatique
MX2016013046A (es) 2014-04-04 2017-02-15 Intra-Cellular Therapies Inc Compuestos organicos.
BR112016023162B1 (pt) 2014-04-04 2022-11-29 Intra-Cellular Therapies, Inc Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
US10179776B2 (en) 2014-06-09 2019-01-15 Intra-Cellular Therapies, Inc. Compounds and methods of use to treat schizophrenia
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
US20170298055A1 (en) 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
US20170291889A1 (en) 2014-09-17 2017-10-12 Ironwood Pharmaceuticals, Inc. Pyrazole derivatives as sgc stimulators
EP3194386A2 (fr) 2014-09-17 2017-07-26 Ironwood Pharmaceuticals, Inc. Stimulateurs de sgc
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US9808608B2 (en) * 2014-11-16 2017-11-07 International Business Machines Corporation Helical coil delivery device for active agent
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
BR112018012870A2 (pt) 2015-12-30 2018-12-04 Adamas Pharmaceuticals Inc métodos e composições para o tratamento de transtornos relacionados à crise
BR112018015283B1 (pt) 2016-01-26 2023-09-26 Intra-Cellular Therapies, Inc Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
EP3888656A1 (fr) 2016-03-25 2021-10-06 Intra-Cellular Therapies, Inc. Composés gamma-carbolines deutérés hétérocycliques et leur utilisation pour le traitement ou la prévention d'un désordre du système nerveux central
WO2017172795A1 (fr) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Nouvelles compositions et méthodes
CA3018019A1 (fr) 2016-03-28 2017-10-26 Opko Ireland Global Holdings, Limited Procedes de traitement par la vitamine d
BR112018073511A2 (pt) 2016-05-16 2019-03-26 Intarcia Therapeutics, Inc. polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7258561B2 (ja) * 2016-07-06 2023-04-17 オリエント ファーマ シーオー．，エルティーディー． 薬物組成物、バリヤー層及び薬物層を有している経口投与形態
BR112019004468A2 (pt) 2016-09-02 2019-05-28 Ironwood Pharmaceuticals Inc estimulantes de sgc
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
CN110267949A (zh) 2016-11-08 2019-09-20 塞科里昂医疗股份有限公司 sGC刺激剂
EP3538096B1 (fr) 2016-11-08 2024-02-28 Tisento Therapeutics Inc. Traitement de maladies du snc au moyen de stimulateurs de gcs
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018126143A1 (fr) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Composés organiques
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
CA3054841A1 (fr) 2017-03-24 2018-09-27 Intra-Cellular Therapies, Inc. Nouvelles compositions et methodes
WO2018200885A1 (fr) 2017-04-26 2018-11-01 Neurocentria, Inc. Compositions de magnésium et méthodes d'utilisation
WO2019023063A1 (fr) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Composés organiques
MX2020000968A (es) 2017-07-26 2020-09-28 Intra Cellular Therapies Inc Compuestos organicos.
MX2020009668A (es) 2018-03-16 2021-01-08 Intra Cellular Therapies Inc Métodos novedosos.
EP3768254A4 (fr) 2018-03-23 2021-11-10 Intra-Cellular Therapies, Inc. Composés organiques
WO2019204187A1 (fr) * 2018-04-15 2019-10-24 Optofluidic Bioassay, Llc Système de drainage assisté par pression différentielle
JP7483671B2 (ja) 2018-06-11 2024-05-15 イントラ－セルラー・セラピーズ・インコーポレイテッド 置換ヘテロ環縮合ガンマ－カルボリン類合成
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
EP3843738A4 (fr) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. Nouvelles méthodes
WO2020047408A1 (fr) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Nouvelles méthodes
US10940088B1 (en) * 2020-01-09 2021-03-09 King Saud University Method of preparing low dose pharmaceutical formulations
CN112641751B (zh) * 2020-09-25 2022-06-21 广州玖洲胶囊生物科技有限公司 一种羟丙甲基纤维素和卡拉胶的填充空心充液胶囊
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US4203440A (en) 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
PT100944B (pt) * 1991-10-10 2000-02-29 Alza Corp Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
EP0768867B1 (fr) * 1994-06-13 2002-10-09 Alza Corporation Forme galenique pour l'administration d'un medicament dans une formulation liquide
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
IT1289160B1 (it) 1997-01-08 1998-09-29 Jagotec Ag Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
CN1161101C (zh) * 1998-12-17 2004-08-11 阿尔扎有限公司 用多层包衣将填充液体的明胶胶囊转变成控制释放的系统

Also Published As

Publication number Publication date
CN1331580A (zh) 2002-01-16
CA2354472C (fr) 2009-02-24
US20020155154A1 (en) 2002-10-24
JP2002532406A (ja) 2002-10-02
DE69915346D1 (de) 2004-04-08
ATE260642T1 (de) 2004-03-15
ZA200104928B (en) 2002-06-18
NO20012959D0 (no) 2001-06-15
MXPA01006108A (es) 2002-09-18
DK1140012T3 (da) 2004-07-12
HUP0104721A2 (en) 2002-06-29
CN1161101C (zh) 2004-08-11
WO2000035419A3 (fr) 2000-11-09
EP1140012B1 (fr) 2004-03-03
EP1140012A2 (fr) 2001-10-10
WO2000035419A2 (fr) 2000-06-22
NO20012959L (no) 2001-08-10
US20010036472A1 (en) 2001-11-01
KR20010087422A (ko) 2001-09-15
PT1140012E (pt) 2004-05-31
HUP0104721A3 (en) 2006-07-28
DE69915346T2 (de) 2004-07-22
CA2354472A1 (fr) 2000-06-22
US6929803B2 (en) 2005-08-16
AU765909C (en) 2004-09-23
IL143691A (en) 2009-02-11
AU765909B2 (en) 2003-10-02
KR100634069B1 (ko) 2006-10-16
HK1040632A1 (en) 2002-06-21
ES2213404T3 (es) 2004-08-16
CO5271648A1 (es) 2003-04-30
NZ512410A (en) 2003-02-28
AU2199400A (en) 2000-07-03
US6419952B2 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
HK1040632A1 (en) Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings.
ES2075444T3 (es) Sistema de dosificado osmotico para la administracion de un farmaco liquido.
DE59507193D1 (de) VERFAHREN ZU hERSTELLUNG EINER MANTELTABLETTE MIT SPITZEM KERN
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
GR3001238T3 (en) Process for the preparation of an administration and dosage for drugs, reagents or other active substances
ES282407U (es) Una capsula osmotica para la liberacion a velocidad controlada de una formulacion de un agente util
WO2000025753A3 (fr) Administration regulee d'agents actifs
AU4927090A (en) Medicaments having controlled release of the active compound
IE880281L (en) Swellable pellets
WO1995022974A3 (fr) Comprimes enrobes de paracetamol et de domperidone
WO2004028504A8 (fr) Formes de dosage a liberation modifiee
EP0616802A4 (fr) Preparation administree par voie orale et destinee a etre liberee dans le tube digestif inferieur.
HRP20020165B1 (en) Low-dose tablets and preparation method
HU9603565D0 (en) Carbamazepine medicament with retarded active substance release
JPS5721316A (en) Plaster
HUP0100769A3 (en) Liquid pharmaceutical formulation containing zotepine as active agent
JPS53142519A (en) Coating solution for printable sugar coated tablet
MXPA05003280A (es) Formas de dosis de liberacion modificada.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed